Ergoteles’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-42,122
| Closed | -$178K | – | 1020 |
|
|
2023
Q1 | $178K | Buy |
+42,122
| New | +$178K | 0.01% | 1030 |
|
|
2022
Q3 | – | Sell |
-214,700
| Closed | -$2.51M | – | 1519 |
|
|
2022
Q2 | $2.51M | Buy |
+214,700
| New | +$2.51M | 0.08% | 266 |
|
|
2021
Q2 | – | Sell |
-18,100
| Closed | -$256K | – | 1466 |
|
|
2021
Q1 | $256K | Buy |
+18,100
| New | +$256K | 0.01% | 591 |
|